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Abstract 48 
Background: Several prognostic models have been developed trying to estimate the risk of 49 
mortality after surgery for active infective endocarditis (IE). However, these models 50 
incorporate different predictors and their performance is uncertain.  51 
Objective: We aimed to systematically review and critically appraise all available prediction 52 
models of post-operative mortality in patients with IE, and to synthesize them into a meta-53 
model. 54 
Data sources: We searched Medline and EMBASE databases from inception to June 2020 to 55 
identify post-operative prognostic models.  56 
Study eligibility criteria: We included studies that developed or updated a prognostic model 57 
of post-operative mortality in patient with IE.  58 
Methods: We assessed the risk of bias of the models using PROBAST (Prediction model Risk 59 
Of Bias ASsessment Tool) and we synthesized them into an aggregate meta-model based on 60 
stacked regressions and optimized it for a nationwide registry of IE patients. The meta-model 61 
performance was assessed using bootstrap validation methods and adjusted for optimism.  62 
Results: We identified 9 studies reporting the development of 11 prognostic models for post-63 
operative mortality. Eight models were rated as high risk of bias. The meta-model included 64 
weighted predictors from the remaining three models (i.e. EndoSCORE, specific ES-I and 65 
specific ES-II), which were not rated as high risk of bias and provided full model equation. 66 
Additionally, two variables (i.e. age and infectious agent) which had been modelized 67 
differently across studies, were estimated from scratch based on the nationwide registry. The 68 
meta-model performance was better than that of initial three models, with the corresponding 69 
performance measures: C-statistics 0.79 (95% CI 0.76 to 0.82), calibration slope 0.98 (95% 70 
CI 0.86 to 1.13) and calibration-in-the-large -0.05 (95% CI -0.20 to 0.11).  71 
Conclusions: The meta-model outperformed published models and showed a robust predictive 72 
capacity for predicting the individualized risk of post-operative mortality in patients with IE.  73 
Protocol Registration: PROSPERO (registration number CRD42020192602) 74 
Key words: Prognostic models, systematic review, meta-model, aggregation, validation, 75 
infective endocarditis. 76 
  77 
Background 78 
Infective endocarditis (IE) is an uncommon but severe disease with a high mortality rate. Its 79 
current estimated incidence is 3-10 episodes per 100.000 person-years, while its in-hospital 80 
mortality rate ranges between 15% and 40% (1,2). Management of IE is often complex and, 81 
although indications for surgery are established in current guidelines (3), the decision whether 82 
to perform surgery remains a challenge because of the high mortality rate associated with the 83 
procedure. For that reason, it is estimated than less than half of the patients with surgical 84 
indication finally undergo cardiac surgery (4)leading to a significant decreased chance of 85 
survival (5). In this context, there has been a great interest on modeling prognosis of patients 86 
with IE to accurately estimate the risk of mortality and to help in the decision-making processes.  87 
In the last decade, several IE prognostic models using preoperative patient´s-related and IE-88 
specific factors, have been proposed (6). Unfortunately, these models have not been 89 
implemented in guidelines or applied in clinical practice. In fact, clinicians seldomly trust these 90 
models because they have usually been built in relatively small cohorts and have not been 91 
externally validated. Consequently, researchers carry on developing new models from their own 92 
data without considering prior knowledge, which leads to an scenario with multiple prognostic 93 
models of dubious validity. Therefore, we aimed to systematically review and critically 94 
appraise all available prediction models for post-operative mortality in patients with IE, and to 95 
synthesize them into a meta-model based on stacked regressions.  96 
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Methods 98 
The protocol for this study was registered on PROSPERO (registration number 99 
CRD42020192602). We designed this systematic review according to the recent guidance by 100 
Debray et al.(7,8),  and reported its results following PRISMA (Preferred Reporting Items for 101 
Systematic Reviews and Meta-Analyses) (9) and TRIPOD (Transparent Reporting of a 102 
Multivariable Prediction Model for Individual Prognosis or Diagnosis) (10,11) 103 
recommendations.  104 
Literature search 105 
We searched Medline through Ovid and Embase through Elsevier from inception to 106 
01/06/2020. We conducted a literature search to identify all potential studies for inclusion. We 107 
applied no restriction considering language or publication dates. We used the methodologic 108 
filter developed by Geersing et al. for prediction models research in MEDLINE (12), which 109 
was adapted for EMBASE. We added terms related to cardiac surgery and 110 
endocarditis. We further searched bibliographic references of included articles to 111 
identify other potential eligible studies. Complete search strings are shown in 112 
Supplementary Material: S1.  113 
Eligibility criteria 114 
We included original studies that developed prognostic models, with or without external 115 
validation, to predict the risk of post-operative mortality after cardiac surgery in patient with 116 
IE, as well as studies that updated previously published models. We accepted the authors` 117 
definition of post-operative mortality (either 30 days and/or in-hospital mortality), but excluded 118 
models that predicted mortality as part of a composite adverse outcome. Titles, abstracts, and 119 
full texts were screened for eligibility in pairs by three reviewers 120 
independently (BMFF, LVB, ACP) using EPPI-Reviewer 4 (13). Discrepancies were 121 
resolved by consensus.  122 
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Data extraction 123 
Data extraction of included articles was done by three reviewers independently 124 
(pairs from BMFF, LVB, ACP). Reviewers used a standardized data extraction form based on 125 
CHARMS (CHecklist for critical Appraisal and data extraction for systematic Reviews of 126 
prediction Modelling Studies) (8), and discrepancies were solved by consensus. We extracted 127 
data on the following items: general information of the study, source of data, participants´ 128 
characteristics, outcome definition and time of occurrence, candidate predictors, and analysis 129 
methods. (Supplementary Material: S2). When the completed model equation or relevant data 130 
were not provided, we contacted the correspondence authors to require this information. 131 
Risk of bias assessment 132 
We used a standardized form based on PROBAST (PRediction model risk of Bias ASsessment 133 
Tool) (14,15) to evaluate risk of bias (RoB) and applicability. We defined the presence of RoB 134 
as the existence of deficiencies in the study design or analysis that may have led to 135 
systematically distorted estimates of the model performance or its composition. Concerns 136 
regarding the applicability of a primary study would arise when the population, predictors, or 137 
outcomes of the study differed from those specified in our review question. RoB and 138 
applicability were assessed by two independent reviewers (pairs from BMFF, LVB, ACP). We 139 
evaluated the relevant items on the following domains: Participants, predictors, outcome and 140 
analysis. Each domain was rated according to our review question as having a high, low or 141 
unclear RoB, and as providing high, low or unclear concerns regarding applicability. Any 142 
discrepancies were discussed between reviewers and resolved through discussion. The 143 
supplementary material provides details on critical appraisal and applicability (Supplementary 144 
Material: S3). 145 
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GAMES registry 146 
We used the infective endocarditis nationwide Spanish registry (GAMES) 147 
as the validation dataset, to 148 
estimate existing model` weights for the meta-model development and its validation, and to 149 
externally validate the previously published models. Since January 2008, all consecutive 150 
episodes of IE in 34 Spanish hospitals were prospectively registered in GAMES 151 
using a standardized form. 152 
Regional and local ethics committees approved the study, and patients gave their informed 153 
consent in each center. For the present study, we selected all the infective episodes (n=1,453) 154 
registered in the GAMES cohort involving adult patients (aged ≥18 years) who had undergone 155 
cardiac surgery with preoperative diagnosis of active IE. From these, 354 (24.4%) died after 156 
surgery (273 in the first 30 days and the remaining 81 during hospitalization). Supplementary 157 
Material: Table S1 shows the main descriptive characteristic of patients in the validation 158 
nationwide registry.  159 
Statistical analyses 160 
The validation dataset was depurated for the outcomes and predictors included in the prognostic 161 
models included in the systematic review. 162 
Model aggregation was based on stacked regressions (16), which allows the synthesis of 163 
literature models in a meta-model using the prior evidence optimized for the validation dataset 164 
(17,18). Only the models that reported the full model equation and were not flagged as high 165 
risk of bias were considered for aggregation. Stacked regressions used the linear predictor of 166 
each model as a co-variable in the meta-model, and subsequently created a linear combination 167 
of model predictions. That is, the original coefficients of each model are weighted by an 168 
independent parameter estimated in the meta-model, so that the models with worse performance 169 
in the validation dataset are penalized more. When aggregation of the coefficients was not 170 
Código de campo cambiado
Código de campo cambiado
possible, either because the definition of the predictor from primary studies was too 171 
heterogeneous or because predictors had been modeled differently in the published models (for 172 
instance, a numerical variable treated as a continuous predictor in one model and being 173 
categorized at different cut-points in the others), these predictors were dropped, and were 174 
included in the meta-model as independent covariables to re-estimate their coefficients entirely 175 
from scratch based on the validation dataset. Non-linear relationships for continuous predictors 176 
were tested using fractional polynomials (19). 177 
Predictors with missing data in the validation dataset were imputed under the missing at random 178 
assumption using multiple imputation with chained equations (20). We included all predictors 179 
and the outcome in the imputation models to ensure compatibility. (Supplementary Material: 180 
S4). Imputation checks were completed by looking at the distributions of imputed values to 181 
ensure plausibility. We generated 10 multiple imputed datasets and all primary analyses were 182 
performed in each imputed dataset. Pooled parameters were estimated both in the aggregation 183 
and validation processes using Rubin’s rules (21). 184 
The model validation was assessed in terms of discrimination (i.e. through the use of the C-185 
statistic, with values from 1 indicating perfect discrimination to 0.5 no discrimination) and 186 
calibration (i.e. through the calibration slope and calibration-in-the-large [CITL], with 1 and 0 187 
as ideal values, respectively; as well as with calibration plots). Calibration plots represent the 188 
average predicted probability for risk groups categorized using deciles of predicted probability 189 
against observed proportion in each group, and fitting a less smoother to show calibration 190 
across the entire range of predicted probabilities at the individual-level (22,23). For the 191 
calibration plots we used the average predicted probabilities for individuals by pooling the 192 
imputed datasets using Rubin’s rules (21). Because the meta-model was optimized to the 193 
validation dataset, we assessed its optimism-corrected performance measures by applying 194 
bootstrap validation with 500 replicates. As sensitivity analyses, we tested all model 195 
Código de campo cambiado
Código de campo cambiado
Código de campo cambiado
Código de campo cambiado
Código de campo cambiado
performance regardless of their critical appraisal. In addition, the meta-model performance was 196 
assessed only for 30-days mortality to investigate the meta-model robustness. 197 
All analyses were performed using Stata software version 16 (24). 198 
  199 
Código de campo cambiado
Results 200 
Literature search and study selection 201 
We retrieved 4,862 titles through our systematic search combining Medline and Embase. From 202 
these, 684 duplicate references were identified. Of 4,178 titles assessed by title and abstract, 34 203 
studies were retained for full text screening, and 2 additional studies were detected in the 204 
bibliographic references of these articles. Nine studies describing 11 prediction models met the 205 
inclusion criteria (Figure 1 and Supplementary Table S2).  206 
Source of data and participants 207 
All prognostic model development studies were carried out in the last decade. Six used data 208 
from a study cohort (three of them from a single center (25–27) and three from multiple centers 209 
(28–30)); two studies used data from multicenter registries (6,31); and one study used data 210 
from both a multicenter cohort and a local clinical registry (32). Eight studies used data from 211 
patients in Europe (Spain, Italy, France or Portugal) and one from patients in North America. 212 
Participants were recruited between 1980 and 2015. (Supplementary Table S3).  213 
Outcomes 214 
Three models were developed to predict any death occurring before discharge or within 30 days 215 
of surgery (6,25,27), five models were built to predict any death occurring before discharge  216 
(26,30–32), and the remaining three models predicted death within 30 days of surgery (28, 217 
29). The incidence of deaths varied between 8.2% and 29.2% (Table 1).  218 
Predictors 219 
The number of candidate predictors considered in the models varied from 15 to 57 and included 220 
patient-, clinical-, surgery- and IE-related factors. The number of parameters retained in the 221 
final models ranged from 2 to 15 (Table 1): The most common factors were critical 222 
preoperative state (n=9), renal failure (n = 7), age (n = 6), New York Heart Association (NYHA) 223 
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classification (n = 6), paravalvular complications (n = 6) and infection etiology (n = 5). The 224 
predictor definitions and the models’ composition are shown in the Supplementary Table S4 225 
and Table S5. 226 
Model development and presentation 227 
Sample sizes for models’ development varied between 128 and 13,617 patients, and the 228 
number of events ranged from 21 and 1,117. Only two models from the same study adequately 229 
informed the handling of missing data (29), and these used complete data analyses. Logistic 230 
regression analysis was the most common modelling technique (n = 9), while logistic mixed 231 
effects (28) and logistic GEE (Generalized Estimating Equation) models (6) were only used in 232 
one model development each. Nine models used univariable analyses to select the candidate 233 
predictors. In nine out of eleven models the number of events per parameter (EPP) assessed for 234 
inclusion in the final model were lower than the minimum required for development of a 235 
new prediction model, based on the sample size estimation proposed by Riley et al.(33,34) 236 
(Supplementary Table S6). The method of predictors selection during multivariable modelling 237 
was backward selection in three models (26,32), stepwise selection in two models (30,31), and 238 
an automatic algorithm based on Akaike information criteria in multiple bootstrap samples in 239 
the other two models, with predictors selected in at least 70% of the bootstrapped samples being 240 
included in the final model (29). Four models did not inform about the method used to select 241 
predictors. (Table 1) 242 
In seven out of 11 models the authors did not inform the complete model equation, and five of 243 
them did not respond when were asked for further details 244 
(Supplementary Table S7). Nine models were presented as a scoring system, and two of them 245 
included nomograms.  246 
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Model performance 247 
The model performance was assessed in terms of discrimination in all models through the C-248 
statistic. Nevertheless calibration was often wrongly assessed using the Hosmer-Lemeshow test 249 
(37) in six models. Only three models (27,29) used calibration slopes and CITL. Eight models 250 
were internally validated: three models were evaluated by bootstrapping with correction for 251 
optimism (28,29), one was assessed through the 0.632 bootstrap method (26), two used 252 
temporal split samples (32) and two used random split samples (6,30). Three models only 253 
estimated the apparent performance (25,27,31). Three models were externally validated in the 254 
same development study using very small sample sizes, with only 18 events in the Olmos’ 255 
model (30) and 21 in the Gatti’s model (32).  Clinical utility of the models was never assessed. 256 
Risk of bias 257 
The RoB was high in eight models, unclear in one (28) and low in the remaining two (29) 258 
(Table 1, Supplementary Table S8 and Figure S1). Two of the eight models with high RoB 259 
scored at “high risk” in the participants domain. Eight models scored at “high risk” in the 260 
analysis domain. Most of the models had small sample sizes and the number of EPP was 261 
close to 1 in several models, increasing the risk of overfitting (34). Many studies decided model 262 
predictors based on univariable analysis, three reported only the apparent performance and two 263 
used random splitting validation. The calibration was sub-optimally assessed in all models 264 
classified as high risk of bias, with most of them using the Hosmer-Lemeshow test.   265 
Derivation of the Meta-model 266 
The eight models with high RoB were excluded from the statistical synthesis so that only the 267 
EndoScore, Specifics EuroSCORE-I (Specific ES-I and EuroSCORE-II (Specific ES-II) 268 
models were aggregated in the meta-model. The model developed by Di Mauro (EndoSCORE) 269 
(28) included 15 parameters, while the other two (Specific ES-I and Specific ES-II) developed 270 
by Fernández-Hidalgo (29), presented 10 and 9 parameters respectively, from the EuroSCORE 271 
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models predictors (35, 36) and IE-related factors (Table 2 and Supplementary Table S7). The 272 
dependent variable for the meta-model was mortality (either 30-days or in-hospital).  273 
To construct the meta-model, we first calculated the linear predictors (LP) from EndoSCORE, 274 
Specific ES-I and Specific ES-II for each observation in the validation dataset, after dropping 275 
the parameters for age and infection etiology because these variables were modelized 276 
differently in the different studies. Subsequently, we adjusted the meta-model using a logistic 277 
regression model, which incorporated the LPs as co-variables, to estimate the models’ weights 278 
for aggregation, as well as the predictors for age (treated as continuous) and infection etiology 279 
(categorized into three groups: Staphylococcus spp, fungi and other microorganisms) to re-280 
estimate the coefficients from scratch. The meta-model included 18 parameters from the 281 
predictors included in at least one of the three original models (Table 2). 282 
Validation of the models 283 
The three prediction models considered for aggregation and the meta-model were validated in 284 
the GAMES registry. The C-statistics and their 95% confidence intervals (95%CI) for the 285 
published models were: 0.76 (95% CI 0.73 to 0.79) for EndoSCORE, 0.76 (95% CI 0.73 to 286 
0.79) for Specific ES-I, and 0.73 (95% CI 0.73 to 0.79) for Specific ES-II. The optimism 287 
adjusted C-statistic for the meta-model was 0.79 (95% CI 0.76 to 0.82) (Figure 2). Calibration 288 
slopes were < 1 for all published models: 0.80 (95% CI 0.69 to 0.92) for EndoScore, 0.82 (95% 289 
CI 0.70 to 0.94) for Specific ES-I, and 0.76 (95% CI 0.65 to 0.87) for Specific ES-II. CITL was 290 
0.58 (95% CI 0.44 to 0.71) for EndoSCORE and 0.62 (95% CI 0.48 to 0.76) for Specific ES-291 
II, and -0.02 (95% CI -0.16 to 0.11) for Specific ES-I. Optimism adjusted calibration measures 292 
for the meta-model were 0.98 (95% CI 0.86 to 1.13) for the slope and -0.05 (95% CI -0.20 to 293 
0.11) for CITL (Figure 2). The calibration plots for the three previously published models and 294 
the meta-model are shown in Figure 3.  295 
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Sensitivity analysis showed that the meta-model had better overall performance than all 296 
published models regardless of their quality assessment (Supplementary Figure S2). 297 
Moreover, even though the meta-model was not fitted for the 30-days mortality outcome, it 298 
outperformed the three models used for model aggregation. (Supplementary Figure S3) 299 
  300 
Discussion 301 
Summary of findings 302 
In this systematic review of prediction models for post-operative mortality in patients with 303 
infective endocarditis, we identified and critically appraised 11 models developed in 9 studies. 304 
The predicted outcome varied between studies (in-hospital, 30-days or both in-hospital or 30-305 
days mortality). Of the eleven prognostic models, only two had low RoB and one 306 
unclear, the remained eight models had high RoB mainly owing to poor 307 
statistical methods used, which suggests that their predictive performance when used in practice 308 
is probably lower than that reported. The sample sizes used to develop the models were limited 309 
and this is a well-known problem that leads to inaccurate predictions and consequently incorrect 310 
healthcare decisions in practice (34). 311 
Four out of the 11 published models reported the full model equation required for a models’ 312 
aggregation and a complete independent external validation as recommended by reporting 313 
guidelines (10,11). Two models’ equations were recovered asking correspondence authors. 314 
Three models that were not flagged as high RoB could be used to create the meta-model.  315 
Our meta-model showed better performance than the existing models. We investigated the 316 
internal validity of the meta-model using bootstrap validation, and the results indicate there was 317 
no substantial over-optimism and that the validation sample was sufficiently large to combine 318 
and update the published models. Therefore, the meta-model is likely less prone to over-319 
optimism and more generalizable to new patient populations or settings, because it was built 320 
from the evidence of several patient cohorts and optimized to a nationwide registry. 321 
Strengths and limitations 322 
To our knowledge, this is the first systematic review of prediction models of post-operative 323 
mortality in patients with infective endocarditis with a complete external validation. We only 324 
combined the published prediction models with low or unclear RoB and adjusted them to a new 325 
patient population. We used multiple imputation of predictors to avoid loss of useful 326 
information. The resulting meta-model incorporated prior knowledge optimally and 327 
outperformed previously published models. 328 
Our study has some limitations. The outcome definition in the validation dataset was either 30-329 
days or in-hospital post-operative mortality, and the outcome definition in the three models 330 
used for aggregation was 30-days mortality. Despite this difference a sensitivity analysis 331 
showed that the meta-model outperformed all published models when we explored its 332 
performance for the 30-days mortality. The meta-model did not include some predictors that 333 
were associated with post-operative mortality from the models with high RoB. 334 
Nevertheless, except type-of-valve which was included in several models (27,30,31), the 335 
remaining predictors were each only included in one model. Unfortunately, although we 336 
identified 11 prediction models in our systematic review, we were only able to validate the 337 
models that published the complete model equation. Although the definition of predictors in 338 
GAMES registry was standardized, these could differ from definitions of published studies. 339 
Comparison to existing studies 340 
Most studies to develop new prediction models are based on small sample sizes and the 341 
modelling strategies are excessively driven by available data without considering the previous 342 
knowledge, leading to inefficient models. Other authors carried out external validation studies 343 
but none of them made a critical appraisal (38–41). In a previous study, Varela et. al. developed 344 
a prognostic meta-model based on a systematic review of pre-operative factors related to in-345 
hospital mortality, however, it was built using multiple univariate meta-analyses of the crude 346 
associations, without considering possible covariable correlations (42,43). 347 
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Implications for practice  348 
The decision whether to perform surgery in IE remains a challenge in clinical practice and it 349 
should come after a careful balance between the procedural risk and its estimated benefit. 350 
Although risk scores in predicting mortality do not offer help in terms of establishing the 351 
burdens of surgical futility, they apport a great value helping endocarditis teams to manage that 352 
complex disease. 353 
Although in the 2015 IE guidelines the score created by De Feo-Cotrufo et al for native IE is 354 
the only one recommended, it would be expected to change with the creation of several new 355 
IE specific scores and the generation of a meta-model that outperformed existing models. 356 
Challenges and opportunities 357 
Further external validation studies are necessary to confirm the improvement in predictive 358 
ability of the meta-model. We will develop an online calculator to allow a simple and effective 359 
use of the meta-model. Given the low incidence of infective endocarditis, available sufficient 360 
sample sizes for the adequate development of new predictive models are difficult to come by. 361 
We encourage authors to make their data available in order to allow building models based on 362 
available data (44). 363 
Conclusions 364 
The meta-model we built is a robust prognostic model to calculate the individualized risk of 365 
post-operative mortality in patients with infective endocarditis. It was developed based on the 366 
previous evidence using aggregation methods of the existing models identified from a 367 
systematic review and after critical being appraised. This meta-model outperformed existing 368 
models; therefore, this preoperative tool can help guide individually tailored choices made by 369 
patients and clinicians. 370 
  371 
Código de campo cambiado
Authors contributions 372 
Conceptualization: BMFF, LVB, JLA, AM, JIP, MR, JRM, EGE, JZ; Search strategies: 373 
BMFF, NAD, JLA; Data extraction and Critical appraisal: BMFF, LVB, ACP; Methodology: 374 
BMFF, EGE, AM, JZ; Software, Formal analysis: BMFF; Validation: AM, JZ; Data 375 
adquisition/curation: BMFF, ENE, PM, MCF, MAG: Writing - Original draft: BMFF, EGE, 376 
JZ; Visualization: BMFF, LVB, NFH; Supervision: EGE, JZ; Writing – Review & Editing: 377 
All authors.  378 
Bibliography 379 
1.  Murdoch DR. Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in 380 
the 21st Century: The International Collaboration on Endocarditis–Prospective Cohort 381 
Study. Arch Intern Med. 2009 Mar 9;169(5):463.  382 
2.  Thuny F, Grisoli D, Collart F, Habib G, Raoult D. Management of infective endocarditis: 383 
challenges and perspectives. The Lancet. 2012 Mar;379(9819):965–75.  384 
3.  Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta J-P, Del Zotti F, et al. 2015 385 
ESC Guidelines for the management of infective endocarditis: The Task Force for the 386 
Management of Infective Endocarditis of the European Society of Cardiology 387 
(ESC)Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the 388 
European Association of Nuclear Medicine (EANM). Eur Heart J. 2015 Nov 389 
21;36(44):3075–128.  390 
4.  Iung B, Doco-Lecompte T, Chocron S, Strady C, Delahaye F, Le Moing V, et al. Cardiac 391 
surgery during the acute phase of infective endocarditis: discrepancies between 392 
European Society of Cardiology guidelines and practices. Eur Heart J. 2016 Mar 393 
7;37(10):840–8.  394 
5.  Chu VH, Park LP, Athan E, Delahaye F, Freiberger T, Lamas C, et al. Association between 395 
surgical indications, operative risk, and clinical outcome in infective endocarditis: a 396 
prospective study from the International Collaboration on Endocarditis. Circulation. 397 
2015 Jan 13;131(2):131–40.  398 
6.  Gaca JG, Sheng S, Daneshmand MA, O’Brien S, Rankin JS, Brennan JM, et al. Outcomes 399 
for endocarditis surgery in North America: A simplified risk scoring system. The Journal 400 
of Thoracic and Cardiovascular Surgery. 2011 Jan;141(1):98-106.e2.  401 
7.  Debray TPA, Damen JAAG, Snell KIE, Ensor J, Hooft L, Reitsma JB, et al. A guide to 402 
systematic review and meta-analysis of prediction model performance. BMJ. 2017 Jan 403 
5;i6460.  404 
8.  Moons KGM, de Groot JAH, Bouwmeester W, Vergouwe Y, Mallett S, Altman DG, et al. 405 
Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling 406 
Studies: The CHARMS Checklist. PLoS Med. 2014 Oct 14;11(10):e1001744.  407 
9.  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting 408 
Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med. 409 
2009 Jul 21;6(7):e1000097.  410 
10.  Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent reporting of a 411 
multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the 412 
TRIPOD statement. BMJ. 2015 Jan 7;350:g7594.  413 
11.  Moons KGM, Altman DG, Reitsma JB, Ioannidis JPA, Macaskill P, Steyerberg EW, et al. 414 
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or 415 
Código de campo cambiado
Diagnosis (TRIPOD): Explanation and Elaboration. Annals of Internal Medicine. 2015 Jan 416 
6;162(1):W1.  417 
12.  Geersing G-J, Bouwmeester W, Zuithoff P, Spijker R, Leeflang M, Moons K. Search 418 
Filters for Finding Prognostic and Diagnostic Prediction Studies in Medline to Enhance 419 
Systematic Reviews. Smalheiser NR, editor. PLoS ONE. 2012 Feb 29;7(2):e32844.  420 
13.  Thomas, J., Graziosi, S., Brunton, J., Ghouze, Z., O’Driscoll, P., & Bond, M. (2020). EPPI-421 
Reviewer: advanced software for systematic reviews, maps and evidence synthesis. 422 
EPPI-Centre Software. London: UCL Social Research Institute.  423 
14.  Moons KGM, Wolff RF, Riley RD, Whiting PF, Westwood M, Collins GS, et al. PROBAST: 424 
A Tool to Assess Risk of Bias and Applicability of Prediction Model Studies: Explanation 425 
and Elaboration. Ann Intern Med. 2019 Jan 1;170(1):W1.  426 
15.  Wolff RF, Moons KGM, Riley RD, Whiting PF, Westwood M, Collins GS, et al. PROBAST: 427 
A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies. Ann 428 
Intern Med. 2019 Jan 1;170(1):51.  429 
16.  Breiman L. Stacked regressions. Mach Learn. 1996 Jul;24(1):49–64.  430 
17.  Debray TPA, Koffijberg H, Nieboer D, Vergouwe Y, Steyerberg EW, Moons KGM. Meta-431 
analysis and aggregation of multiple published prediction models: Meta-analysis and 432 
aggregation of multiple published prediction models. Statist Med. 2014 Jun 433 
30;33(14):2341–62.  434 
18.  Martin GP, Mamas MA, Peek N, Buchan I, Sperrin M. A multiple-model generalisation of 435 
updating clinical prediction models. Statistics in Medicine. 2018 Apr 15;37(8):1343–58.  436 
19.  Royston P, Sauerbrei W. Multivariable model-building: a pragmatic approach to 437 
regression analysis based on fractional polynomials for modelling continuous variables. 438 
Chichester, England ; Hoboken, NJ: John Wiley; 2008. 303 p. (Wiley series in probability 439 
and statistics).  440 
20.  White IR, Royston P, Wood AM. Multiple imputation using chained equations: Issues 441 
and guidance for practice. Statist Med. 2011 Feb 20;30(4):377–99.  442 
21.  Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York: Wiley; 1987.  443 
22.  Riley RD, Windt D van der, Croft P, Moons KGM. Prognosis research in healthcare: 444 
concepts, methods and impact. 2019.  445 
23.  Steyerberg EW. Clinical Prediction Models: A Practical Approach to Development, 446 
Validation, and Updating [Internet]. 2019 [cited 2020 Apr 28]. Available from: 447 
https://doi.org/10.1007/978-3-030-16399-0 448 
24.  StataCorp. 2019. Stata Statistical Software: Release 16. College Station, TX: StataCorp 449 
LLC.  450 
25.  De Feo M, Cotrufo M, Carozza A, De Santo LS, Amendolara F, Giordano S, et al. The 451 
Need for a Specific Risk Prediction System in Native Valve Infective Endocarditis 452 
Surgery. The Scientific World Journal. 2012;2012:1–8.  453 
26.  Gatti G, Benussi B, Gripshi F, Della Mattia A, Proclemer A, Cannatà A, et al. A risk factor 454 
analysis for in-hospital mortality after surgery for infective endocarditis and a proposal 455 
of a new predictive scoring system. Infection. 2017 Aug;45(4):413–23.  456 
27.  Madeira S, Rodrigues R, Tralhão A, Santos M, Almeida C, Marques M, et al. Assessment 457 
of perioperative mortality risk in patients with infective endocarditis undergoing 458 
cardiac surgery: performance of the EuroSCORE I and II logistic models. Interact 459 
CardioVasc Thorac Surg. 2016 Feb;22(2):141–8.  460 
28.  Di Mauro M, Dato GMA, Barili F, Gelsomino S, Santè P, Corte AD, et al. A predictive 461 
model for early mortality after surgical treatment of heart valve or prosthesis infective 462 
endocarditis. The EndoSCORE. International Journal of Cardiology. 2017 Aug;241:97–463 
102.  464 
29.  Fernández-Hidalgo N, Ferreria-González I, Marsal JR, Ribera A, Aznar ML, de Alarcón A, 465 
et al. A pragmatic approach for mortality prediction after surgery in infective 466 
endocarditis: optimizing and refining EuroSCORE. Clinical Microbiology and Infection. 467 
2018 Oct;24(10):1102.e7-1102.e15.  468 
30.  Olmos C, Vilacosta I, Habib G, Maroto L, Fernández C, López J, et al. Risk score for 469 
cardiac surgery in active left-sided infective endocarditis. Heart. 2017 470 
Sep;103(18):1435–42.  471 
31.  Martínez-Sellés M, Muñoz P, Arnáiz A, Moreno M, Gálvez J, Rodríguez-Roda J, et al. 472 
Valve surgery in active infective endocarditis: A simple score to predict in-hospital 473 
prognosis. International Journal of Cardiology. 2014 Jul;175(1):133–7.  474 
32.  Gatti G, Perrotti A, Obadia J, Duval X, Iung B, Alla F, et al. Simple Scoring System to 475 
Predict In‐Hospital Mortality After Surgery for Infective Endocarditis. JAHA [Internet]. 476 
2017 Jul [cited 2020 Dec 28];6(7). Available from: 477 
https://www.ahajournals.org/doi/10.1161/JAHA.116.004806 478 
33.  Riley RD, Snell KI, Ensor J, Burke DL, Harrell Jr FE, Moons KG, et al. Minimum sample 479 
size for developing a multivariable prediction model: PART II - binary and time-to-event 480 
outcomes. Statistics in Medicine. 2019 Mar 30;38(7):1276–96.  481 
34.  Riley RD, Ensor J, Snell KIE, Harrell FE, Martin GP, Reitsma JB, et al. Calculating the 482 
sample size required for developing a clinical prediction model. BMJ. 2020 Mar 483 
18;m441.  484 
35.  Nashef SAM, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European 485 
system for cardiac operative risk evaluation (EuroSCORE). European Journal of Cardio-486 
Thoracic Surgery. 1999 Jul;16(1):9–13.  487 
36.  Nashef SAM, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, et al. EuroSCORE 488 
II. European Journal of Cardio-Thoracic Surgery. 2012 Apr 1;41(4):734–45.  489 
37.  On behalf of Topic Group ‘Evaluating diagnostic tests and prediction models’ of the 490 
STRATOS initiative, Van Calster B, McLernon DJ, van Smeden M, Wynants L, Steyerberg 491 
EW. Calibration: the Achilles heel of predictive analytics. BMC Med. 2019 492 
Dec;17(1):230.  493 
38.  Varela L, López-Menéndez J, Redondo A, Fajardo ER, Miguelena J, Centella T, et al. 494 
Mortality risk prediction in infective endocarditis surgery: reliability analysis of specific 495 
scores†. European Journal of Cardio-Thoracic Surgery. 2018 May 1;53(5):1049–54.  496 
39.  Pivatto Júnior F, Bellagamba CC de A, Pianca EG, Fernandes FS, Butzke M, Busato SB, et 497 
al. Análise de Escores de Risco para Predição de Mortalidade em Pacientes Submetidos 498 
à Cirurgia Cardíaca por Endocardite. ABC Cardiol [Internet]. 2020 [cited 2021 Mar 5]; 499 
Available from: https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-500 
782X2020000300518 501 
40.  Gatti G, Sponga S, Peghin M, Givone F, Ferrara V, Benussi B, et al. Risk scores and 502 
surgery for infective endocarditis: in search of a good predictive score. Scandinavian 503 
Cardiovascular Journal. 2019 May 4;53(3):117–24.  504 
41.  Wang TKM, Oh T, Voss J, Gamble G, Kang N, Pemberton J. Comparison of contemporary 505 
risk scores for predicting outcomes after surgery for active infective endocarditis. Heart 506 
Vessels. 2015 Mar;30(2):227–34.  507 
42.  Varela Barca L, Navas Elorza E, Fernández-Hidalgo N, Moya Mur JL, Muriel García A, 508 
Fernández-Felix BM, et al. Prognostic factors of mortality after surgery in infective 509 
endocarditis: systematic review and meta-analysis. Infection. 2019 Dec;47(6):879–95.  510 
43.  Varela Barca L, Fernández-Felix BM, Navas Elorza E, Mestres CA, Muñoz P, Cuerpo-511 
Caballero G, et al. Prognostic assessment of valvular surgery in active infective 512 
endocarditis: multicentric nationwide validation of a new score developed from a meta-513 
analysis. European Journal of Cardio-Thoracic Surgery. 2020 Apr 1;57(4):724–31.  514 
44.  Debray TPA, Riley RD, Rovers MM, Reitsma JB, Moons KGM, Cochrane IPD Meta-515 
analysis Methods group. Individual Participant Data (IPD) Meta-analyses of Diagnostic 516 
and Prognostic Modeling Studies: Guidance on Their Use. PLoS Med. 2015 Oct 517 
13;12(10):e1001886.  518 
 519 
